Validation of the Double Awareness Scale: A Novel Measure of Psychological Adaptation to Advanced Cancer
Psycho-Oncology · 2026-04 · 35 (4)
DOI: 10.1002/pon.70445 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Psycho-Oncology, online erschienen am 17.04.2026. Verfasst von Melissa Miljanovski und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Supportive Care, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Neoplasms, Quality of Life, Adaptation, Psychological, Awareness. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Individuals with advanced cancer face the challenge of remaining engaged in life, while also contemplating death. However, there has been no validated measure of the adaptive capacity to balance these tasks, which has been termed “double awareness.” Aims This study aimed to evaluate the psychometric properties of the novel Double Awareness Scale (DAS).
Methods
Patients with advanced cancer attending an outpatient palliative care clinic ( N = 197) completed the DAS and other self‐report measures assessing quality of life near end of life, life completion, satisfaction with life, preparation for end of life, death anxiety, and depression. Factor structure, construct validity, and internal consistency of the DAS were evaluated, as were group differences across high, intermediate, and low levels of double awareness.
Results
Factor analysis supported two factors, Life Engagement and Death Contemplation , with high internal consistency ( α = 0.92 and 0.87, respectively). Life Engagement met the convergent validity criterion with quality of life near the end of life ( r = 0.62) and life completion ( r = 0.60), but not with life satisfaction ( r = 0.46). Death Contemplation did not meet the convergent validity criterion with preparation for end of life ( r = 0.23) but demonstrated discriminant validity with death anxiety ( r = −0.03). Those with high levels of double awareness (high Life Engagement and high Death Contemplation ) exhibited the best quality of life and lowest distress.
Conclusions
Preliminary evidence supports the validity of the DAS. Further research is needed to demonstrate its validity in diverse settings, its utility in clinical care, and its responsiveness to therapeutic interventions in the context of advanced disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Supportive Care, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
- Department of Psychology, University of Windsor, Windsor, Ontario, Canada.
- Department of Psychiatry, University of Arizona, Tucson, Arizona, USA.
- Department of Psychiatry, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
- Global Institute of Psychosocial, Palliative and End-of-Life Care (GIPPEC), Princess Margaret Cancer Centre, University Health Network, and University of Toronto, Toronto, Ontario, Canada.
- Department of Medicine, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
Zitieren
APA
Miljanovski, M., Mah, K., Li, A., Rydall, A., McConnell, M. H., Shapiro, G. K., Hannon, B., Zimmermann, C., & Rodin, G. (2026). Validation of the Double Awareness Scale: A Novel Measure of Psychological Adaptation to Advanced Cancer. Psycho-Oncology, 35(4). https://doi.org/10.1002/pon.70445
Vancouver
Miljanovski M, Mah K, Li A, Rydall A, McConnell MH, Shapiro GK, et al. Validation of the Double Awareness Scale: A Novel Measure of Psychological Adaptation to Advanced Cancer. Psycho-Oncology. 2026;35(4). doi:10.1002/pon.70445
BibTeX
@article{Miljanovski2026,
author = {Miljanovski, Melissa and Mah, Kenneth and Li, Athena and Rydall, Anne and McConnell, Mairead H and Shapiro, Gilla K and Hannon, Breffni and Zimmermann, Camilla and Rodin, Gary},
title = {Validation of the Double Awareness Scale: A Novel Measure of Psychological Adaptation to Advanced Cancer},
journal = {Psycho-Oncology},
year = {2026},
volume = {35},
number = {4},
doi = {10.1002/pon.70445}
}
EUVIMED